NIAID created global network to advance development of HIV vaccines
On May 25, 2000, the National Institute of Allergy and Infectious Diseases (NIAID) announced funding of nine U.S….
On May 25, 2000, the National Institute of Allergy and Infectious Diseases (NIAID) announced funding of nine U.S….
On Feb. 17, 2000, the Food and Drug Administration (FDA) announced it it had licensed a 13-valent pneumococcal…
In 2000, the use of Oral polio vaccine (OPV) was discontinued in the U.S. to eliminate the risk…
In 2000, measles was declared no longer endemic in the U.S. following eradication campaigns that began in 1967….
On Dec. 9, 1999, the diphtheria and tetanus toxoids and acellular pertussis vaccine (Tripedia by Connaught) was licensed….
On Nov. 23, 1999, the Bill & Melinda Gates Foundation pledged a gift of $750 million over five…
On Oct. 22, 1999, the Advisory Committee on Immunization Practices (ACIP), after a review of scientific data from…
On Oct. 15, 1999, Wyeth-Lederle Vaccines announced that it was withdrawing the Rotashield vaccine from the market and…
In August 1999, an outbreak of encephalitis caused by West Nile virus (WNV) was detected in New York…
On Jun. 17, 1999, the Immunization Practices Advisory Committee (ACIP) recommended exclusive use of inactivated poliovirus vaccine (IPV)…
On Jun. 9, 1999, the Dale and Betty Bumpers Vaccine Research Center (VRC) was established at the National…
In April 1999, a pandemic planning framework was published by the World Health Organization (WHO) that emphasized the…
On Jan. 15. 1999, the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices…
In 1999, a meningococcal group C conjugate vaccine was introduced into the routine schedule in the U.K. for…
In 1999, the U.S. Centers for Disease Control and Prevention (CDC) launched the National Pharmaceutical Stockpile, now the…
In 1999, the U.S. Centers for Disease Control and Prevention (CDC) established the Laboratory Response Network (LRN). The…
On Dec. 21, 1998, the Lyme Disease Vaccine (Recombinant OspA), (LYMErix by SmithKline Beecham) was licensed for use…
On Aug. 31, 1998, Rotashield (Wyeth Laboratories, Marietta, Pennsylvania) was licensed by the U.S. Food and Drug Administration…
On Aug. 26, 1998, the Children’s Vaccine Program was established at WHO’s Program for Appropriate Technology in Health…
On Jul. 29, 1998, the diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (Certiva by North American…
In March 1998, the Stop TB Initiative was established following a meeting of the First Ad hoc Committee…
In 1998, some research caused concern that hepatitis B vaccination might be linked with multiple sclerosis (MS), a…
On Oct. 20, 1997, the Food and Drug Administration (FDA) licensed Purified Chick Embryo Cell (PCEC, RabAvert®) vaccine…
On April 4, 1997, the Immunization Practices Advisory Committee (ACIP) recommended that the vaccine be used more extensively…
On Feb. 13, 1997, the American Association for the Advancement of Science (AAAS) Annual Meeting and Science Innovation…
In 1997, the Immunization Practices Advisory Committee (ACIP) recommended adoption of a sequential series of two doses of…
In 1997, FluNet, a global web-based tool for influenza virological surveillance was launched. It is a critical tool…
In 1997, the H5N1 bird flu incident in Hong Kong was the first known instance of a purely…
On Dec. 30, 1996, the Food and Drug Administration (FDA) announced it had licensed three DTaP vaccines for…
On Oct. 2, 1996, the Food and Drug Administration (FDA) licensed a combined Hib conjugate and hepatitis B…